Game Plan Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.91K Hold
175
﹤0.01% 237
2025
Q4
$4.36K Hold
175
﹤0.01% 244
2025
Q3
$4.46K Hold
175
﹤0.01% 251
2025
Q2
$4.24K Hold
175
﹤0.01% 256
2025
Q1
$4.43K Hold
175
﹤0.01% 260
2024
Q4
$4.63K Sell
175
-805
-82% -$21.8K ﹤0.01% 270
2024
Q3
$28.4K Hold
980
0.01% 164
2024
Q2
$27.4K Sell
980
-2,120
-68% -$58.4K 0.01% 168
2024
Q1
$86K Buy
3,100
+2,925
+1,671% +$81.2K 0.04% 125
2023
Q4
$5.04K Buy
+175
New +$5.29K ﹤0.01% 292
2022
Q1
Sell
-3,650
Closed -$216K 114
2021
Q4
$216K Buy
+3,650
New +$181K 0.12% 87

Other funds holding PFE

Game Plan Financial Advisors's PFE Position: Q1 2026 in Review

Game Plan Financial Advisors held its Pfizer (PFE) position steady in Q1 2026 at 175 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Game Plan Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 11 quarters since. The position peaked at $216K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Game Plan Financial Advisors held 175 shares of Pfizer worth $4.91K as of Q1 2026.
  • Game Plan Financial Advisors left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up ﹤0.01% of Game Plan Financial Advisors's portfolio in Q1 2026, its #237 holding.
  • Game Plan Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 11 quarters since.
  • Game Plan Financial Advisors's Pfizer position peaked at $216K in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Game Plan Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.